Difference between revisions of "Section 1: Introduction (from DOI: 10.1080/22221751.2020.1735265)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(Created page with "<b>From publication:</b> "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking...")
 
 
Line 1: Line 1:
 +
{{infobox_publicationsection}}
 +
 
<b>From publication:</b> "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)" in the journal Emerg Microbes Infect (2020)<br> https://doi.org/10.1080/22221751.2020.1735265<br><h3><u>Section 1: Introduction</u></h3><p>Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a novel type of coronavirus of beta genus that leads to an emerging infectious disease with remarkable pulmonary involvement in China since December 2019. The clinical features include fever, dry cough, shortness of breath, normal or low levels of peripheral white blood cells, and inflammatory changes on chest X-ray. China has designated SARS-CoV-2 infected pneumonia as a statutory infectious disease. To standardize the clinical diagnosis and treatment, Peking Union Medical College Hospital (PUMCH) has established a working group and formulated the following operational recommendation regarding "Diagnosis and Clinical Management of Severe Acute Respiratory Syndrome Coronavirus 2 Infection" (V2.0).</p><small><b><em>Go to [[Section 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265)|next section]] in publication</em></b></small>
 
<b>From publication:</b> "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)" in the journal Emerg Microbes Infect (2020)<br> https://doi.org/10.1080/22221751.2020.1735265<br><h3><u>Section 1: Introduction</u></h3><p>Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a novel type of coronavirus of beta genus that leads to an emerging infectious disease with remarkable pulmonary involvement in China since December 2019. The clinical features include fever, dry cough, shortness of breath, normal or low levels of peripheral white blood cells, and inflammatory changes on chest X-ray. China has designated SARS-CoV-2 infected pneumonia as a statutory infectious disease. To standardize the clinical diagnosis and treatment, Peking Union Medical College Hospital (PUMCH) has established a working group and formulated the following operational recommendation regarding "Diagnosis and Clinical Management of Severe Acute Respiratory Syndrome Coronavirus 2 Infection" (V2.0).</p><small><b><em>Go to [[Section 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265)|next section]] in publication</em></b></small>

Latest revision as of 19:17, 14 May 2020


Navigation
ArticleDiagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) (DOI: 10.1080/22221751.2020.1735265)
Sections in this Publication
SectionSection 1: Introduction (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 2.1: Selection of front-line personnel (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 2.2: Isolation and protection requirements (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 2.3: Isolation and observation of medical personnel after close contact with SARS-CoV-2 (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3: Diagnosis and treatment of SARS-CoV-2 infected patients (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.1: Screening criteria (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.2: Diagnostic criteria (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.3: Examination routines of SARS-CoV-2 infected patient (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.3.1: Screening cases on the day of visit (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.3.2: Sequential examination of confirmed patients (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.4: Place of treatment according to the severity of the disease (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.4.1: Severe type (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.4.2: Critically ill type (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.5.1: General treatment (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.5.2: Oxygen therapy (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.5.2.1: Choice of oxygen therapy (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.5.2.2: The way of respiratory support (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.5.3: Antiviral treatment (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.5.5: Intravenous immunoglobulin (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 3.5.6: Empirical antimicrobial therapy (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 4: Protection and transfer (from DOI: 10.1080/22221751.2020.1735265)
SectionSection 5: Criteria of isolation release and discharge (from DOI: 10.1080/22221751.2020.1735265)
Named Entities in this Section

From publication: "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)" in the journal Emerg Microbes Infect (2020)
https://doi.org/10.1080/22221751.2020.1735265

Section 1: Introduction

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a novel type of coronavirus of beta genus that leads to an emerging infectious disease with remarkable pulmonary involvement in China since December 2019. The clinical features include fever, dry cough, shortness of breath, normal or low levels of peripheral white blood cells, and inflammatory changes on chest X-ray. China has designated SARS-CoV-2 infected pneumonia as a statutory infectious disease. To standardize the clinical diagnosis and treatment, Peking Union Medical College Hospital (PUMCH) has established a working group and formulated the following operational recommendation regarding "Diagnosis and Clinical Management of Severe Acute Respiratory Syndrome Coronavirus 2 Infection" (V2.0).

Go to next section in publication